Fenofibrate 160mg Tablets

Fenofibrate 160mg is a fibrate lipid-lowering medicine used mainly for high triglycerides and mixed dyslipidemia when diet, weight, exercise, diabetes control, and other risk-management steps are not enough. It activates PPAR-alpha pathways, increasing breakdown of triglyceride-rich particles and improving lipid patterns. Fenofibrate can lower triglycerides and may raise HDL cholesterol, but it is not a substitute for statin therapy when statins are needed for LDL or cardiovascular-risk reduction. Very high triglycerides may increase pancreatitis risk, so treatment goals depend on baseline lipids and overall risk. Fenofibrate should be used with a lipid-focused diet and follow-up testing rather than as a stand-alone cholesterol fix.
Take Fenofibrate 160mg as prescribed, consistently with the same food instructions for the specific product. Keep lipid, liver, and kidney monitoring appointments. Continue diet, activity, weight, alcohol, and diabetes-control measures.
Fenofibrate activates PPAR-alpha, increasing lipoprotein lipase activity and triglyceride-rich particle clearance while reducing VLDL production.
Possible effects include abdominal pain, nausea, headache, back pain, raised liver enzymes, and digestive upset. Serious warning signs include unexplained muscle pain or weakness, dark urine, jaundice, severe abdominal pain, gallbladder symptoms, or allergic reaction.
Review kidney disease, liver disease, gallbladder disease, pancreatitis, hypothyroidism, diabetes, pregnancy, breastfeeding, alcohol use, statins, colchicine, warfarin, and other lipid medicines.
High triglycerides and mixed dyslipidemia when fenofibrate is prescribed as part of a lipid-management plan.
Can substantially reduce triglycerides and improve lipid balance, helping manage pancreatitis risk in very high triglycerides and mixed lipid disorders.
Fenofibrate 160mg is used to lower high triglycerides and manage mixed dyslipidemia when prescribed.
No. Diet, weight management, exercise, diabetes control, and alcohol reduction remain important.
Fenofibrate can affect liver enzymes and kidney-related safety decisions, so monitoring guides continued use.
Unexplained muscle pain, weakness, tenderness, or dark urine should be reported urgently.
Sometimes, but the prescriber must weigh benefit against increased muscle-injury risk.
Fenofibrate, Fibrate lipid medicine, High triglyceride treatment, PPAR alpha agonist, Mixed dyslipidemia, Muscle injury warning, AR: Fenofibrate أقراص, FR: Fenofibrate comprimé, PT: Fenofibrate comprimido, ES: Fenofibrate tableta, RU: Fenofibrate таблетки, ID: Fenofibrate, VI: Fenofibrate viên nén, MS: Fenofibrate, TL: Fenofibrate tableta, ZH-SG: Fenofibrate 片剂
International B2B Enquiry
Send a structured B2B enquiry for Fenofibrate 160mg Tablets under Cardiac Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Fenofibrate 160mg Tablets